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Abstract: 
On March 11, 2011, a devastating earthquake and subsequent tsunami caused serious 
damage to areas of the Pacific coast in Fukushima prefecture and prompted fears among 
the residents about a possible meltdown of the Fukushima Daiichi Nuclear Power Plant 
reactors. As of 2017, over six years have passed since the Fukushima nuclear crisis and 
yet the full ramifications of the biological exposures to this accidental release of 
radioactive substances remain unclear. Furthermore, although several genetic studies 
have determined that the variation in radiation sensitivity among different individuals is 
wider than expected, personalized medical approaches for Fukushima victims have 
seemed to be insufficient. In this commentary, we discuss radiobiological issues arising 
from low-dose radiation exposure, from the cell-based to the population level. We also 
introduce the scientific utility of the Integrative Japanese Genome Variation Database 
(iJGVD), an online database released by the Tohoku Medical Megabank Organization, 
Tohoku University that covered the whole genome sequences of 2049 healthy individuals 
in the northeastern part of Japan in 2016. Here we propose a personalized radiation risk 
assessment and medical approach, which considers the genetic variation of radiation 
sensitivity among individuals, for next-step developments in radiological protection. 
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Commentary: 
In March of 2011, the northeastern part of Japan was devastated by the triple disasters of 
an earthquake, a tsunami, and the Fukushima Daiichi Nuclear Power Plant (FNPP) 
accident (Shibahara 2011), leaving local residents fearful about the long-term health risk 
of low-dose radiation because of radioactive substances released from the FNPP (Ishigaki 
et al. 2013; Fukunaga and Kumakawa 2015). As of 2017, unfortunately, the ramifications 
of biological exposure to low dose radiation remains unclear (Hosoda et al. 2016). 
Previous epidemiological data indicate a clear increase in the long-term risk of 
cancer from exposure to radiation at doses exceeding 100 mSv. For this reason, following 
Japan’s worst ever radiation accident at FNPP, radiation doses have been measured in the 
Fukushima residents, using both personal dosimeters for external exposure and whole-
body counters for internal exposure (Yasumura et al. 2012). Several studies have 
indicated that the radiation exposure levels of Fukushima residents are much lower than 
predicted (Hayano et al. 2013; Kamiya et al. 2016). Furthermore, Harada et al. showed 
that the mean annual radiation dose rate in 2012 associated with the accident was 0.89–
2.51 mSv/y and the mean dose rate estimates for 2022 are comparable with the variations 
of the average 2 mSv/y background radiation due to exposure to natural radionuclides in 
Japan (Harada et al. 2014). These findings suggest that the extra lifetime integrated dose 
after 2012 will increase the estimated lifetime risk of cancer incidence by a factor of 1.03 
to 1.05 at most, which is unlikely to be epidemiologically detectable (Harada et al. 2014). 
In 2013, the World Health Organization (WHO) reported that the estimates of 
radiation-induced health risks in Japan for the lifetime risk for some cancers may be 
somewhat elevated above baseline rates in certain age and sex groups among residents of 
the areas most affected by the FNPP accident (WHO 2013). Also, the United Nations 
Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) published a report 
suggesting that a general radiation-related increase in the incidence of health effects 
among the exposed population would be indiscernible over the baseline level; however, 
it could not rule out the possibility of excess cases of disease due to irradiation, nor to the 
possibility of detection of a biomarker for certain types of cancer  in certain subgroups 
being identified in the future that could be associated with radiation exposure (UNSCEAR 
2014; UNSCEAR 2015). In addition, the dose-response relation for cancer at low doses 
is assumed, for purposes of radiological protection, to be linear and without a threshold, 
but this has not been definitively confirmed for all exposure scenarios. An appropriate 
dose-response relation for the effects of low doses of radiation therefore remains to be 
established (Kamiya et al. 2015). 
 The knowledge accumulated concerning the risks of low-dose radiation exposure 
to humans appears to be insufficient at this time because of important radiological issues 
arising at low doses due to inhomogeneous dose distribution in living systems. In general, 
the energy deposition of radiation is localized along its track, resulting in a heterogeneous 
distribution of exposed or unexposed cells in an organ. A Monte Carlo track simulation 
study reported that roughly 50% of the cell nuclei in a cell population receive a “hit” from 
a radiation track produced by an acute exposure of 270 Gy of 137Cs -rays (Watanabe 
2012). This situation differs substantially from that in higher dose regions when analyzed 
by the concept of “absorbed dose.” Instead, an “elemental dose,” given by a single 
radiation track to a target volume, as developed by microdosimetry, should be used in the 
analysis of low-dose effects (ICRU 1983). This dose was estimated as 0.87 mGy for 60Co 
-rays by Booz and Feinendegen in 1998 (Booz and Feinendegen 1988). In this low-dose 
situation, two groups exist in a cell population: one consists of cells that received the 
elemental dose from a single track, and the other consists of cells that did not receive any 
dose. Although several papers reveal the clinical utility of inhomogeneous dose 
distribution in tissue-based level such as micro-slit-beam radiation therapy using 
synchrotron-generated X-ray beams (Mukumoto et al. 2017), to our knowledge, the 
radiation risk assessment of such inhomogeneous dose distribution in a living system has 
not yet been determined. Thus, two main factors are recognized as governing the 
biological influences of low-dose irradiation. The first is the radiation-induced bystander 
effect (RIBE) at the cell or tissue levels (Nagasawa and Little 1992; Prise and O’Sullivan 
2009; Blyth and Sykes 2011), and the second is radiation sensitivity at the individual or 
population levels (Fukunaga et al. 2016; Fukunaga and Yokoya 2016). 
 A simple definition of RIBE is that “a cell responds to the fact that its neighbor(s) 
have been irradiated” (Fig. 1), and a key characteristic of RIBE, in contrast to direct 
irradiation effects, is the dose-response relationship. Instead of an increased response with 
an increasing radiation dose, the RIBE becomes saturated at relatively low doses 
(typically less than 1 Gy) (Prise and O’Sullivan 2009). Since the first report of RIBE by 
Nagasawa and Little (Nagasawa and Little 1992), low-dose radiation research, pursued 
in a variety of experimental systems that have focused on cultured cells, has suggested 
that DNA damage and genetic instability due to RIBE are responsible for some of the 
effects of low-dose radiation on cells (Prise and O’Sullivan 2009; Blyth and Sykes 2011). 
However, the underlying biological mechanism has yet to be clarified, thereby 
maintaining the assessment of radiation risks at low doses in a very controversial status. 
To our knowledge at this time, the data accumulated concerning the cancer risks of RIBE 
at individual levels appears to be insufficient (Blyth and Sykes 2011). The radiation 
exposure levels of local residents have truly been extremely low after the FNPP accident; 
however, the future effects on people’s health remain in doubt because of the lack of 
knowledge of the underlying mechanism of the biological effects of low-dose radiation, 
including RIBE. 
 Severe reactions to radiation therapy have been reported in clinical practice in 
individuals suffering from DNA damage response (DDR) defective disorders, such as 
ataxia-telangiectasia (AT), Nijmegen breakage syndrome, Fanconi anemia, and DNA 
ligase IV deficiency (Pollard and Gatti 2009). These patients, and other heterozygous 
carriers, can be associated with radiation hypersensitivity, as well as with cancer 
predisposition, although the underlying mechanism of radiation-induced carcinogenesis 
in these individuals remains to be determined (Jongmans and Hall 1999). Additionally, 
several single nucleotide polymorphisms (SNPs) have been reported as potential 
biomarkers for predicting the development of radiation pneumonitis (RP), one of the 
adverse effects of radiation therapy. These SNPs in genes related to DDR, cell signaling, 
and inflammation have a statistically confirmed association with RP, suggesting their 
direct or indirect involvement in radiation sensitivity (Zhang et al. 2010; Yin et al. 2011; 
Yin et al. 2012; Edvardsen et al. 2013; Tang et al. 2016). In 2016, we reported the 
estimated prevalence of heterozygous careers of major DNA repair disorders in 
Fukushima, such as AT, Werner syndrome, and hereditary breast ovarian cancer 
syndrome (Fukunaga and Yokoya 2016). 
 We used the Integrative Japanese Genome Variation Database (iJGVD, available 
at https://ijgvd.megabank.tohoku.ac.jp/) in 2016 to investigate the variations in these 
radiosensitivity-related gene in a large population. This is an online database released by 
the Tohoku Medical Megabank Organization, Tohoku University that covered the whole 
genome sequences of 2049 healthy individuals in the part of northeastern Japan that was 
seriously damaged in the 2011 disaster (Nagasaki et al. 2015; Yamaguchi-Kabata et al. 
2015). We found that a large number of individuals have SNPs associated with the risk 
of developing RP, indicating a greater than expected genetic diversity of radiation 
sensitivity (Fukunaga et al. 2016). We also investigated the frequency of mutations in the 
WRN gene among residents in the northeastern part of Japan to determine the presence of 
Werner syndrome (WS) patients and/or WRN heterozygous carriers. This syndrome is a 
rare genetic disorder that causes deficiency of the WRN protein and presents with features 
suggestive of accelerated aging and radiation hypersensitivity (UNSCEAR 2011). 
Genetic instability has been observed in WS patients and in WRN heterozygotes, 
suggesting an association between WRN gene mutations and radiation hypersensitivity, 
as well as cancer predisposition, in these persons (Moser et al. 2000). To our knowledge, 
our result is the first evidence of a direct link between the presence of heterozygous 
carriers with genetic instability and radiation hypersensitivity in the northeastern part of 
Japan after the 2011 FNPP accident (data not shown). Consideration of these patients and 
heterozygous carriers with other radiation sensitivity disorders would give a much wider 
than expected individual variation in radiation sensitivity. 
The target of current medical approaches has shown a gradual change from the 
“average person” to “each person.” However, in the matter of radiation protection, this 
approach has not been sufficiently developed (Fukunaga et al. 2016). Using the iJGVD 
and other databases, we are now investigating the heterozygous carriers of these disorders 
in the northeastern part of Japan including Fukushima, however because of the sample 
size we cannot significantly detect such high-risk individuals, with the exception of the 
WRN heterozygous mutation carriers. Other diseases including Cockayne’s syndrome are 
extremely rare, therefore heterozygous carriers could not be significantly detected 
because of methodological limitations. It is true that the iJGVD has great potential for 
future innovations from the view point of precision medicine, nevertheless, the present 
sample size is too small and needs to be urgently expanded. As previously mentioned, 
several genomic studies have recently determined a wider than expected variation in 
radiation sensitivity among individuals, indicating an inadequacy in the conventional 
approach to radiological protection. As shown in Fig. 2, we need a personalized radiation 
risk assessment and care approach that considers the genetic variation of radiation 
sensitivity in individuals to replace the current dose-dependent risk assessment approach. 
Appropriate actions are expected in Fukushima health facilities for the coming era of 
precision medicine. 
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Figure Legends 
Fig. 1. Radiation-induced bystander effect. 
Cells that did not directly receive radiation doses but did receive signals from nearby or 
neighboring irradiated cells behave as though they have been exposed, showing genomic 
instability and other abnormalities. The effect is mediated either through gap junctions or 
via soluble factors released by irradiated cells. 
 
Fig. 2. Personalized radiation risk assessment and care system in the large-scale nuclear 
accident management. 
There are two radiation risk assessment and care systems after the nuclear accident: the 
dose-dependent (A) and the personalized (B). High, moderate, and low radiation-induced 
health risk parson are shown in red, yellow, and green, respectively. 
 
